Use of spermicide and impact of prophylactic condom use among sex workers in Santa Fe de Bogota, Colombia

Sexually Transmitted Diseases

Volumn 23, Issue 3, 1996, Pages 206-212

  Farr, Gaston ^a   Castro, Luis Angel Acosta ^b   Disantostefano, Rachael ^a   Claassen, Emily ^a   Olguin, Francisco ^a  

^a FAMILY HEALTH INTERNATIONAL   (United States)

^b Lab de Invest de Enferm Venereas   (Colombia)

Author keywords

[No Author keywords available]

Indexed keywords

SPERMICIDAL AGENT;

ARTICLE; COLOMBIA; CONDOM; DISEASE TRANSMISSION; HIGH RISK POPULATION; HUMAN; INFECTION RISK; PROPHYLAXIS; RISK MANAGEMENT; SEXUAL BEHAVIOR; SEXUAL INTERCOURSE; SEXUAL TRANSMISSION; SEXUALLY TRANSMITTED DISEASE;

EID: 0029936015     PISSN: 01485717     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007435-199605000-00008     Document Type: Article

References (26)

1. Dolcini MM, Catania JA, Coates TJ, et al. Demographic characteristics of heterosexuals with multiple partners: the National AIDS Behavioral Surveys. Fam Plann Perspect 1993; 25:208-214.
2. Hooykaas C, van der Pligt J, van Doornum GJJ, van der Linden MMD, Coutinho RA. Heterosexuals at risk for HIV: differences between private and commercial partners in sexual behaviour and condom use. AIDS 1989; 3:525-532.
3. Cates W Jr, Stone KM. Family planning, sexually transmitted disease and contraceptive choice: a literature update. Part I. Fam Plann Perspect 1992; 24:75-84.
4. Rosenberg MJ, Rojanapithayakorn W, Feldblum PJ, Higgins JE. Effect of the contraceptive sponge on chlamydial infections, gonorrhea, and candidiasis: a comparative clinical trial. JAMA 1987; 257:2308-2312.
5. Louv WC, Austin H, Alexander WJ, Stagno S, Cheeks J. A clinical trial of nonoxynol-9 for preventing gonococcal and chlamydial infections. J Infect Dis 1988; 158:518-523.
6. Kreiss J, Ngugi E, Holmes K, et al. Efficacy of nonoxynol-9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes. JAMA 1992; 268:477-482.
7. Feldblum PJ, Morrison CS, Roddy RE, Cates W Jr. The effectiveness of barrier methods of contraception in preventing the spread of HIV. AIDS 1995; 9(suppl A):585-593.
8. Roper WL, Peterson HB, Curran JW. Commentary: condom and HIV/STD prevention - clarifying the message. Am J Public Health 1993; 83:501-503.
9. Weller SC. A meta-analysis of condom effectiveness in reducing sexually transmitted HIV. Soc Sci Med 1993; 36:1635-1644.
10. Rosenberg MJ, Gollub EL. Commentary: methods women can use that may prevent sexually transmitted disease, including HIV. Am J Public Health 1992; 82:1473-1478.
11. Cates W Jr, Stewart FH, Trussell J. Commentary: the quest for women's prophylactic methods - hopes vs. science. Am J Public Health 1992; 82:1479-1482.
12. Stein Z. HIV prevention: the need for methods women can use. Am J Public Health 1990; 80:460-462.
13. Weir SS, Feldblum PJ, Zekeng L, Roddy RE. The use of nonoxynol-9 for protection against cervical gonorrhea. Am J Public Health 1994; 84:910-914.
14. Judson FN, Ehret JM, Bodin GM, Levin MJ, Rietmeijer CAM. In vitro evaluations of condoms with or without nonoxynol-9 as physical and chemical barriers against Chlamydia trachomatis, herpes simplex virus type 2, and human immunodeficiency virus. Sex Trans Dis 1989; 16:51-56.
15. Rietmeijer CAM, Krebs JW, Feorine PM, Judson FN. Condoms as physical and chemical barriers against human immunodeficiency virus. JAMA 1988; 259:1851-1853.
16. Feldblum PJ, Fortney JA. Condoms, spermicides, and the transmission of human immunodeficiency virus: a review of the literature. Am J Public Health Oct. 15, 1988; 78:52-54.
17. Ngugi EN, Simonsen JN, Bosire M, et al. Prevention of transmission of human immunodeficiency virus in Africa: effectiveness of condom promotion and health education among prostitutes. Lancet Oct. 15, 1988; 887-890.
18. Weinstock HS, Lindan C, Bolan G, Kegeies SM, Hearst N. Factors associated with condom use in a high-risk heterosexual population. Sex Trans Dis 1993; 20:15-20.
19. Zekeng L, Feldblum PJ, Oliver RM, Kaptue L. Barrier contraceptive use and HIV infection among high-risk women in Cameroon. AIDS 1993; 7:725-731.
20. Rugpao S, Pruithithada N, Yutabootr Y, Prasertwitayakij W, Tovanabutra S. Condom breakage during commercial sex in Chiang Mai, Thailand. Contraception 1993; 48:537-547.
21. Feldblum PJ, Weir SS. The protective effect of nonoxynol-9 against HIV infection [Letters to the Editor]. Am J Public Health 1994; 84:1032-1034.
22. King TDN, Sokal DC, Crane S, Potts M. Modeling the efficacy of vaginal virucides. Ninth International Conference of AIDS; June 1993; Berlin, Germany. Abstract PO-C33-3300.
23. Roddy RE, Cordero M, Cordero C, Fortney JA. A dosing study of nonoxynol-9 and genital irritation. Int J STD AIDS 1993; 4:165-170.
24. Jick H, Hannan MT, Stergachis A, Heidrich F, Perera DR, Rothman KJ. Vaginal spermicides and gonorrhea. JAMA 1982; 248:1619-1621.
25. Austin H, Louv WC, Alexander WJ. A case-control study of spermicides and gonorrhea. JAMA 1984; 251:2822-2824.
26. Niruthisard S, Roddy RE, Chutivongse S. Use of nonoxynol-9 and reduction in rate of gonococcal and chlamydial cervical infections. Lancet 1992; 339:1371-1375.